Cite

HARVARD Citation

    Huang, A. et al. (2022). Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges. Journal of oncology. p. . [Online]. 
  
Back to record